Skip to main content

Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • Johnson & Johnson receives approval from USFDA and European Commission for SIRTURO (bedaquiline)

    Johnson and Johnson announced that the US Food and Drug Administration has issued traditional approval for SIRTURO bedaquiline as part of combination therapy in adult and pediatric patients 5 years and older and weighing at least 15 kg with pulmonary tuberculosis due to Mycobacterium tuberculosis resistant to at least rifampicin and isoniazid
  • Nerve damage from cancer treatment can be predicted

    Many women treated for breast cancer using taxanes, a type of cytostatic drug, often experience side effects in the nervous system. Researchers at LiU have developed a tool that can predict the risk level for each individual. The tool could help doctors adapt treatment to avoid persistent side effects in those at the greatest risk. 

  • Drugs that kill zombie cells may benefit some older women, but not all, Mayo Clinic study finds
    Drugs that selectively kill senescent cells may benefit otherwise healthy older women but are not a one-size-fits-all remedy, Mayo Clinic researchers have found. Specifically, these drugs may only benefit people with a high number of senescent cells, according to findings published today in Nature Medicine.
  • Low-dose aspirin could help prevent pregnancy complications caused by flu infections
    A world-first study has found low-dose aspirin may treat flu-induced blood vessel inflammation, creating better blood flow to the placenta during pregnancy.
  • Industry Leaders Converge for 4th Computer Software Assurance 2024 : Enhancing Pharma Compliance and Innovation

    The 4th Computer Software Assurance 2024: CSx - Define your Variable and Assure your Validation, held by Eminence Business Media on June 20th-21st, 2024 at Radisson Blu Mumbai International Airport, was a resounding success. The event featured over 100 delegates, and industry leaders offering tailored solutions to streamline the CSV process for pharma companies. With dedicated Q&A rounds, presentations, and case study discussions throughout the day, the event proved to be both informative and interactive.

  • Drug Safety Symposium 2024 – India Chapter Revolutionizing Pharmacovigilance Practices in India

    The Drug Safety Symposium 2024 – India Chapter, held over two action-packed days, brought together industry leaders, experts, and professionals to explore innovative strategies and collaborative efforts in pharmacovigilance. With insightful, interactive, and robust sessions, the event highlighted the future of drug safety in India, emphasizing the importance of regulatory compliance, data integrity, and cutting-edge technologies like AI in enhancing pharmacovigilance systems.

  • Breakthrough research makes cancer-fighting viral agent more effective
    Researchers from Aarhus University have made a significant breakthrough by discovering that the drug 4-OI can enhance the effectiveness of a cancer-fighting viral agent. This may lead to treatment of cancers that are otherwise resistant to therapies.
  • Study reveals why AI models that analyze medical images can be biased
    Artificial intelligence models often play a role in medical diagnoses, especially when it comes to analyzing images such as X-rays. However, studies have found that these models don’t always perform well across all demographic groups, usually faring worse on women and people of color.
  • Cosmohome Tech Expo 2024

    Cosmohome Tech Expo was held in Delhi at Pragati Maidan from 26th to27st June 2024. It was its 10th edition, comprising of more than 350 Exhibitors who displayed  latest Ingredients, Formulations, Fragrances, Packaging, Instruments, Machinery, Labelling and Contract Manufacturing.

  • New Approach Accurately Identifies Medications Most Toxic to the Liver
    The current method for assessing medication-related liver injury is not providing an accurate picture of some medications toxicity or lack thereof to the liver, according to a new study led by researchers from the Perelman School of Medicine at the University of Pennsylvania. Classification of a medication’s potential to damage the liver, termed hepatotoxicity, has been historically determined by counting individual reported cases of acute liver injury
Subscribe to Pharma News